
Daily Newsletter | Wednesday, January 06, 2016 | | | PM Modi’s Pakistan trip no mistake, feels RSS | | The Rashtriya Swayamsewak Sangh may not be ready to see Prime Minister Narendra Modi’s decision to meet his Pakistan counterpart Nawaz Sharif in Lahore as a mistake despite the terror attack on the IAF base at Pathankot as the Sangh sees the timing of any diplomatic initiative as largely the PM’s prerogative. |
|  |
| | 50 men shave heads to mourn Pathankot martyrs | | Unable to go to Pathankot to meet the families of those killed in the terror attack or send then money, 50 young men have shaved off their heads in a symbol of mourning for the martyrs. |
|  |
| | Lenovo Vibe K4 Note first impressions | | Less than a year after the launch of the feature-rich K3 Note, Lenovo is out with the next edition model. Predictably named K4 Note, the latest Lenovo smartphone is a major upgrade over last year's handset not in terms of specs, but in terms of features instead. We went hands-on with Lenovo K4 Note at the launch event to find out what the smartphone is all about. Here's what we thought about it... |
|  |
| CES 2016: The gadget extravaganza | | CES, the biggest gadgets extravaganza of the year, is about to kick off, where a host of companies will showcase technologies that will become the norm in the future. Catch all the action of CES 2016 and latest updates here... |
|  |
| | Will think about retirement at right time: Dhoni | | India's limited overs captain Mahendra Singh Dhoni said he will think about quitting the game at the "right time". "I am a person who lives in the present and the focus right now is the Australian tour leading up to the World T20 Championships. I will think about it at the right time," he said. |
|  |
| | India Inc's Q3 revenue to grow 2%, says study | | Despite a low base effect, India Inc is expected to report a marginal 2% growth in revenues on a yearly basis during the just concluded October-December 2015 (Q3-FY16), thanks mainly to tumbling commodity prices, weak investment demand and flagging rural consumption. |
|  |
| Drug cos face five-fold hike in regulatory fees | | Pharmaceutical companies may have to shell out more to do business in India. The government has proposed an over five-fold hike in regulatory fees for testing, manufacturing and selling medicines in the country, a move that is likely to impact both domestic as well as multinational pharmaceutical companies operating here. |
|  |
| |
|
0 comments:
Post a Comment